Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gauri Saal"'
Autor:
Tingting Qiu, Michal Pochopien, Shuyao Liang, Gauri Saal, Ewelina Paterak, Justyna Janik, Mondher Toumi
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Gene therapies (GTs) are considered to be a paradigm-shifting class of treatments with the potential to treat previously incurable diseases or those with significant unmet treatment needs. However, considerable challenges remain in their health techn
Externí odkaz:
https://doaj.org/article/b57a89d406e24497bed23c955ee85b90
Publikováno v:
Telemedicine and e-Health. 15:1026-1030
The conventional approach to cardiac implantable device follow-up involves patients attending regularly scheduled in-clinic visits to verify the functionality and safety of the implanted devices. Due to increasing patient volumes, as well as the time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e1c6903e8a86b02b43eb0afb1352d31
https://doi.org/10.1089/tmj.2009.0068
https://doi.org/10.1089/tmj.2009.0068
Publikováno v:
International Journal of Clinical Practice. 60:847-855
The highly prevalent, prediabetic condition of impaired glucose tolerance (IGT) confers a high risk for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). There is an emerging body of cost-effectiveness literature in the management of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::186db9b021c98db7048d476aebc7b266
https://doi.org/10.1111/j.1368-5031.2006.00914.x
https://doi.org/10.1111/j.1368-5031.2006.00914.x
Publikováno v:
Journal of Gastroenterology and Hepatology. 17:153-164
BACKGROUND Chronic hepatitis B (CHB) is associated with a significant burden of illness and treatment involves substantial health-care costs. This study estimates clinical outcomes and cost-effectiveness of lamivudine compared with other treatment sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5f0d12b531000342a89959c18f6033
https://doi.org/10.1046/j.1440-1746.2002.02673.x
https://doi.org/10.1046/j.1440-1746.2002.02673.x
Publikováno v:
The American Journal of Gastroenterology. 95:2639-2640
The cost-effectiveness of lamivudine compared with interferon-α for the treatment of chronic hepatitis B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78e945cc5225ef3f1ef281ce87934cad
https://doi.org/10.1016/s0002-9270(00)01938-9
https://doi.org/10.1016/s0002-9270(00)01938-9
Publikováno v:
The American Journal of Gastroenterology. 95:2639-2640
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcc59122b0717a8ad91aa1a66eebf622
https://doi.org/10.1111/j.1572-0241.2000.03146.x
https://doi.org/10.1111/j.1572-0241.2000.03146.x
Publikováno v:
Journal of Wound Care. 18:154-154
Most of the literature focuses on the resources required to manage particular wound types, rather than the cost of wounds to health-care organisations. Until this information is available, wound care is unlikely to be a management priority
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2dffd31b9e170a0966646322e66e3ad
https://doi.org/10.12968/jowc.2009.18.4.41607
https://doi.org/10.12968/jowc.2009.18.4.41607